Literature DB >> 3485541

Type IX collagen is a potent inducer of PGE2 and interleukin 1 production by human monocyte macrophages.

J M Dayer, S Ricard-Blum, M T Kaufmann, D Herbage.   

Abstract

Type IX collagen and its collagenous fragments are potent stimulatory agents on human blood mononuclear cells for the production of prostaglandin E2 and interleukin 1/mononuclear cell factor. Type IX collagen is 2-4-fold more potent that type I and II and 1 alpha-, 2 alpha- and 3 alpha-collagens. This property may be important in the destructive process of cartilage in inflammatory diseases.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3485541     DOI： 10.1016/0014-5793(86)80406-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  5 in total

1.  1,25-Dihydroxyvitamin D3 induces collagen binding to the human monocyte line U937.

Authors:  B S Polla; A M Healy; M Byrne; S M Krane
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the alpha 5 beta 1 integrin.

Authors:  R Pacifici; C Basilico; J Roman; M M Zutter; S A Santoro; R McCracken
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Regulation of human monocyte/macrophage function by extracellular matrix. Adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function.

Authors:  S L Newman; M A Tucci
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Importance of metalloproteinases and macrophages in viper snake envenomation-induced local inflammation.

Authors:  E P Costa; P B Clissa; C F P Teixeira; A M Moura-da-Silva
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

Review 5.  Cytokines in context.

Authors:  C Nathan; M Sporn
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.